nccRCC

Focus on Nonclear Cell RCC: Frontline Treatment Options, Research Limitations, and More
A roundtable discussion, moderated by Brian Rini, MD, addressed considerations for clear versus nonclear cell kidney cancer, as well as recent data from ESMO 2023. Dr. Rini was joined by Tian Zhang, MD; David McDermott, MD; and Hans Hammers, MD. In the next segment of the roundtable series, the panel talks about nonclear cell kidney cancer, including treatment options and clinical trial data in this subgroup. ...
Advertisement
Advertisement

RCC Knowledge Hubs

Renal Cell Carcinoma
Renal Cell Carcinoma

Conference Coverage

Advertisement
Advertisement